Cargando…
Cardiovascular Comorbidities and Pharmacological Treatments of COVID-19 Patients Not Requiring Hospitalization
Introduction: The Coronavirus disease 2019 (COVID-19) outbreak is a whole Earth health emergency related to a highly pathogenic human coronavirus responsible for severe acute respiratory syndrome (SARS-CoV-2). Despite the fact that the majority of infected patients were managed in outpatient setting...
Autores principales: | Russo, Vincenzo, Piccinocchi, Gaetano, Mandaliti, Vincenzo, Annunziata, Saverio, Cimmino, Giovanni, Attena, Emilio, Moio, Nicola, Di Micco, Pierpaolo, Severino, Sergio, Trotta, Roberta, Del Guercio, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795623/ https://www.ncbi.nlm.nih.gov/pubmed/33375676 http://dx.doi.org/10.3390/ijerph18010102 |
Ejemplares similares
-
Heparin and SARS-CoV-2: Multiple Pathophysiological Links
por: Di Micco, Pierpaolo, et al.
Publicado: (2021) -
Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
por: Russo, Vincenzo, et al.
Publicado: (2020) -
Clinical Performance of Oral Anticoagulants in Elderly with Atrial Fibrillation and Low Body Weight: Insight into Italian Cohort of PREFER-AF and PREFER-AF Prolongation Registries
por: Russo, Vincenzo, et al.
Publicado: (2022) -
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study
por: Russo, Vincenzo, et al.
Publicado: (2020) -
Clinical Outcome of Edoxaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation and Diabetes Mellitus: Results from a Multicenter, Propensity-Matched, Real-World Cohort Study
por: Russo, Vincenzo, et al.
Publicado: (2020)